Correlation Between AbbVie and Eton Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AbbVie and Eton Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Eton Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Eton Pharmaceuticals, you can compare the effects of market volatilities on AbbVie and Eton Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Eton Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Eton Pharmaceuticals.

Diversification Opportunities for AbbVie and Eton Pharmaceuticals

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between AbbVie and Eton is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Eton Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eton Pharmaceuticals and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Eton Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eton Pharmaceuticals has no effect on the direction of AbbVie i.e., AbbVie and Eton Pharmaceuticals go up and down completely randomly.

Pair Corralation between AbbVie and Eton Pharmaceuticals

Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Eton Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, AbbVie Inc is 1.92 times less risky than Eton Pharmaceuticals. The stock trades about -0.45 of its potential returns per unit of risk. The Eton Pharmaceuticals is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  1,410  in Eton Pharmaceuticals on January 10, 2025 and sell it today you would lose (213.00) from holding Eton Pharmaceuticals or give up 15.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

AbbVie Inc  vs.  Eton Pharmaceuticals

 Performance 
       Timeline  
AbbVie Inc 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Eton Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Eton Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Eton Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

AbbVie and Eton Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AbbVie and Eton Pharmaceuticals

The main advantage of trading using opposite AbbVie and Eton Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Eton Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will offset losses from the drop in Eton Pharmaceuticals' long position.
The idea behind AbbVie Inc and Eton Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital